---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-21-005210"
form_type: "8-K"
ticker: "SBFM"
cik: "0001402328"
company_name: "Sunshine Biopharma Inc."
filed_at: "2021-11-03T23:59:59+00:00"
generated_at: "2026-06-28T13:49:08.203544+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Sunshine Biopharma expands board to 5, adds 3 independent directors, aims for Nasdaq uplist

## Summary
- Board expanded from 3 to 5 members; added Andrew Telsey (legal), JD Kish (accounting), Dr. Rabi Kiderchah (medical).
- Camille Sebaaly resigned as director but remains CFO.
- New appointments part of Company's application process to uplist to Nasdaq.

## SEC filing metadata
- accession: 0001683168-21-005210
- form_type: 8-K
- ticker: SBFM
- cik: 0001402328
- company_name: Sunshine Biopharma Inc.
- filed_at: 2021-11-03T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1402328/000168316821005210/0001683168-21-005210-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1402328/000168316821005210/sunshine_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-21-005210
- JSON: https://secwatch.observer/filing/0001683168-21-005210.json
- Plain text: https://secwatch.observer/filing/0001683168-21-005210.txt

## Key facts
- Executive change
  JD Kish was appointed as Director at Sunshine Biopharma Inc..
  - Action: added
  - Role: Director
  source text: The Board added Messrs. Andrew Telsey, JD Kish and Dr. Rabi Kiderchah to serve as directors
  evidence_url: https://www.sec.gov/Archives/edgar/data/1402328/000168316821005210/0001683168-21-005210-index.htm
- Executive change
  Rabi Kiderchah was appointed as Director at Sunshine Biopharma Inc..
  - Action: added
  - Role: Director
  source text: The Board added Messrs. Andrew Telsey, JD Kish and Dr. Rabi Kiderchah to serve as directors
  evidence_url: https://www.sec.gov/Archives/edgar/data/1402328/000168316821005210/0001683168-21-005210-index.htm
- Executive change
  Andrew Telsey was appointed as Director at Sunshine Biopharma Inc..
  - Action: added
  - Role: Director
  source text: The Board added Messrs. Andrew Telsey, JD Kish and Dr. Rabi Kiderchah to serve as directors
  evidence_url: https://www.sec.gov/Archives/edgar/data/1402328/000168316821005210/0001683168-21-005210-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.